How Much Does Imbruvica Cost in 2026?

Imbruvica (ibrutinib) is a daily oral therapy for chronic lymphocytic leukemia, Waldenstrom's macroglobulinemia and chronic graft-versus-host disease. Medicare's negotiated price took effect on January 1, 2026: $9,319 for a 30-day supply, 38% below the $14,934 list price CMS used as the comparison. At that price the number that decides what you pay is not the negotiated price at all. It is the annual out-of-pocket cap, and you will reach it on your first or second fill.

  • Medicare's negotiated price is $9,319 per 30-day supply, in effect since January 1, 2026. It is what Medicare and your plan pay, not your copay.
  • This is the smallest percentage cut of the ten first-cycle drugs, 38%, and by far the largest dollar amount.
  • At this price you cross the entire $2,100 annual Part D out-of-pocket cap in your first fill. After that, covered drugs cost you nothing for the rest of the year.
  • Because the whole year's cost can land in January, the Medicare Prescription Payment Plan matters more here than almost anywhere else. It spreads that $2,100 across twelve months.

What You Actually Pay

Figures are for a 30-day supply. List and negotiated prices are from CMS; what you pay depends on your coverage.

Your situationTypical cost
Medicare negotiated price, 2026$9,319 / 30 days
Medicare Part D, your shareup to $2,100 / year
Commercial insurancecopay or coinsurance
Uninsured, cash~$14,934 (list)

Why the Cap Matters More Than the Negotiated Price

The arithmetic is unusual on a drug this expensive. If your plan charges 25% coinsurance on a specialty tier, your share of a single $9,319 fill is about $2,330, which is already more than the $2,100 annual cap. So you pay the cap and stop. Your yearly cost for Imbruvica is, in practice, $2,100, whether the negotiated price is $9,319 or $14,934.

That has two consequences people miss. First, the negotiated price mostly saves Medicare money on this drug, not you, because you were already going to hit the cap. Second, the entire $2,100 can land in January, which is a cash-flow problem rather than a cost problem, and it is exactly what the Medicare Prescription Payment Plan exists to solve. Opt in through your plan and the same total is spread across the year.

What Medicare's Negotiated Price Does, and Does Not, Change

The headline number is not your copay.

$9,319 is the maximum fair price, the amount Medicare and your Part D plan pay for a 30-day supply of Imbruvica. What you are charged at the counter is still set by your plan's tier and cost-sharing rules.

It helps you directly if you pay coinsurance

Many plans charge a percentage of the drug's price on brand and specialty tiers. If you owe 25% of $14,934, that is far more than 25% of $9,319. When your share is a percentage, a lower negotiated price lowers your bill directly.

It may not change a flat copay

If your plan charges a fixed dollar copay for that tier, your copay can stay the same even though the plan is paying less. The benefit then shows up in the program's overall costs rather than your receipt.

It changes how fast you hit the cap

Your spending counts toward the $2,100 annual Part D out-of-pocket cap in 2026. A cheaper drug means a smaller share each month, which can mean you reach the cap later or not at all, so the year-end picture differs from past years.

It does not change coverage rules

A negotiated price does not force a plan to cover Imbruvica, drop prior authorization, or change its tier. Plans still set their own formularies, so check yours before you assume the new price applies to you.

Because tiers and cost-sharing vary so much between plans, the only way to know your real cost is to check Imbruvica against each plan's formulary. If you would rather have that done for you, our Find My Medicare Plan service checks your specific drugs against the plans available to you for a flat $99.

Is There a Generic for Imbruvica?

No. The FDA granted Zydus tentative approval for generic ibrutinib tablets in July 2025, which means the product has been reviewed and found equivalent but cannot be marketed. Imbruvica is covered by a large patent estate and no generic is available in the United States. Treat any website offering "generic Imbruvica" with suspicion.

Does Insurance Cover Imbruvica?

Usually, with conditions

Imbruvica sits on a specialty tier on essentially every Part D plan, which usually means coinsurance rather than a flat copay, and prior authorization is standard. Because every specialty-tier plan lands you at the same $2,100 cap, the differences between plans show up in the deductible and in how fast they process prior authorization, not in the annual total.

If you are denied or moved a tier

A denial is not the end, and a tier change at renewal is not either. Your prescriber can submit a letter of medical necessity or a formulary exception, and you have formal appeal rights. See how to appeal an insurance denial and what to do when a plan drops your drug.

How to Pay Less

Opt into the Medicare Prescription Payment Plan before January

On a drug this expensive your whole annual out-of-pocket can be due with the first fill. This program spreads it evenly across the year at no extra cost. It does not reduce the total, but it prevents the January bill that makes people delay starting treatment.

Ask about the manufacturer and foundation programs

AbbVie runs a patient assistance program, and independent charity foundations grant copay assistance for specific cancers when their funds are open. Foundation grants are allowed alongside Medicare, unlike a manufacturer copay card.

On Medicare, check Extra Help and the payment plan

Extra Help (the Low Income Subsidy) sharply reduces Part D costs and its income limits are higher than most people expect. The Medicare Prescription Payment Plan can also spread your Part D costs evenly across the year instead of front-loading them, and you opt in through your plan.

Check the tier before you commit to a plan

The same drug can cost very different amounts across plans in the same ZIP code. During open enrollment, compare Imbruvica on each plan's formulary, and remember the plan that was cheapest last year may not be this year.

Push back on a bill you have already received

If you were billed more than you expected, or a claim was processed wrong, CareRoute Bill Defense reviews and disputes medical bills, with no fee unless we save you money.

Not sure which plan covers Imbruvica best?

For a flat $99, we research the Medicare plans available to you and check them against your specific drugs and doctors, then hand you a clear comparison. We are independent, sell no insurance, and take no commissions.

Frequently Asked Questions

Is there a generic for Imbruvica?

No. Zydus received FDA tentative approval for generic ibrutinib tablets in July 2025, meaning the product was reviewed and found equivalent but cannot legally be sold yet. Imbruvica remains under patent protection in the United States and no generic version is available at pharmacies. Be wary of any site offering generic Imbruvica.

Why is the cut for Imbruvica only 38% when other drugs got 70% or more?

The Medicare negotiation ceiling depends partly on how long a drug has been on the market. Small-molecule drugs further from their approval date can be discounted more deeply. Imbruvica also started from a much higher base, so a 38% reduction is a larger dollar saving per fill than a 79% cut on a $527 drug. For a patient who reaches the annual out-of-pocket cap either way, the percentage makes little practical difference.

What is Medicare's negotiated price for Imbruvica?

Medicare negotiated a maximum fair price of $9,319 for a 30-day supply of Imbruvica, effective January 1, 2026. That is 38% below the $14,934 list price CMS used as the comparison. Imbruvica was one of the first ten drugs in the Medicare Drug Price Negotiation Program, selected because it was among the highest-spending Part D drugs without generic or biosimilar competition at the time. The price applies automatically at the pharmacy for Part D members.

Will the negotiated price lower what I actually pay for Imbruvica?

It can, but it is not your new copay. The maximum fair price is what Medicare and your Part D plan pay the pharmacy, not automatically what you are charged. If your plan charges coinsurance, a percentage of the drug price, a lower negotiated price lowers your share directly. If your plan charges a flat copay for that tier, your copay may not change at all. Either way, your total Part D out-of-pocket is capped at $2,100 in 2026, after which covered drugs cost you nothing for the rest of the year.

Does insurance cover Imbruvica?

Generally yes. Imbruvica is covered by Medicare Part D and most commercial plans, though plans commonly require prior authorization and sometimes step therapy, meaning you try a cheaper option first. The tier it sits on, not whether it is covered, is usually what decides your cost, and the same drug can sit on different tiers in two plans sold in the same ZIP code. Check your plan's formulary for the tier and any restrictions before you fill it.

Related

Sources

  • CMS, Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026 (maximum fair price and list-price comparison)
  • CMS / Medicare.gov (Part D out-of-pocket cap, $2,100 in 2026, and the $615 maximum deductible)
  • FDA Orange Book and Purple Book (approval and substitutability status for ibrutinib)
  • AbbVie published list price and patient-support program terms

Prices are national figures for a 30-day supply at a common dose and vary by pharmacy, dose, and plan. List prices are the figures CMS published as its negotiation comparison. This page is educational and is not medical or financial advice: do not start, stop, or switch a prescription on the basis of price without talking to your prescriber. Last updated November 20, 2026.